Approach

Method before menu.

What we do is decided by what can be measured, what the evidence supports, and what the result would change. In that order.

How a protocol is set

Every protocol starts from a question that a measurement could answer, and a decision that the answer would change. If there is no such decision, we do not run the test. This rules out a large part of what is sold as preventive medicine.

Once a protocol begins, the re-test date is fixed. Twelve weeks for anything that moves quickly, twenty-four for function and structure. The interval is written down at the first appointment so that neither side can quietly let it drift.

At the re-test we compare against your own previous values, not only against a population reference range. A value inside the range that has moved a long way is often more informative than a value marginally outside it.

How we read evidence

We distinguish four things that are routinely conflated: mechanism, association, randomised outcome data, and marketing. Most longevity claims rest on the first two. That does not make them worthless, but it changes what we are entitled to say about them.

Where a service has cohort data but no outcome trial, we offer it and say so. Where a service has neither, we do not offer it. Where a service has good outcome data for a licensed indication, we prescribe it within that indication and not outside it.

What that means in practice

You will hear qualifications more often than you would elsewhere. When we do not know, the phrase is “we do not know”, and the follow-up is what we would need to measure before we did.

What that means in practice

You will hear qualifications more often than you would elsewhere. When we do not know, the phrase is “we do not know”, and the follow-up is what we would need to measure before we did.

Boundaries

What we deliberately do not do

A practice is defined at least as much by its refusals. These are ours, in the order we are asked about them.

Stem cell and exosome infusions

No randomised outcome evidence in healthy adults, and an unresolved regulatory position in Switzerland. We will not offer these, including on request.

Elective infusions without a deficiency

If your levels are in range, an infusion will not move them usefully. We decline roughly one request a week on this basis.

Biological age scores as a headline number

Epigenetic clocks are interesting research instruments with poor test–retest reliability at the individual level. We do not sell a number that we could not defend on a second draw.

Compounded bioidentical hormones

We prescribe licensed preparations with known dosing and known impurity profiles. Compounded products have neither.

Full-body MRI as a first step

High incidental finding rate, low yield in asymptomatic adults, and a cascade of follow-up that is often harmful. We use imaging when a specific question needs it.

Open-ended supplement protocols

We correct measured deficiencies and stop. We do not run a dispensary and we take no commission on anything we recommend.

Language

Three words we use precisely

Every treatment page carries an evidence note. These are the three grades it can take.

Established

Randomised outcome data, or a measurement whose reliability is well characterised. We state the effect size.

Supported

Consistent cohort or mechanistic evidence without an outcome trial. We offer it and name the gap.

Exploratory

Small or short studies only. Offered as observation, never as a basis for a treatment decision on its own.

Week 0 — this appointmentWeek 12Week 24

First appointment

Start with the baseline.

Ninety minutes, in Zürich or Wien. Nothing is prescribed at the first appointment and nothing is sold.

Request a consultation